Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Rapid Functional Drug Screening of Passage-Zero Patient Brain Tumor Tissues Ex Vivo: Results from a Clinical Feasibility Study.
Journal: Research square
Published: November 24, 2025
Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases.
Journal: Breast (Edinburgh, Scotland)
Published: November 11, 2025
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.
Journal: Neuro-oncology advances
Published: October 24, 2025
Intracranial Activity of Sotorasib in KRASG12C-Mutated Recurrent Glioblastoma.
Journal: JCO precision oncology
Published: April 03, 2025
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 22, 2024
Understanding treatment preferences and cognitive outcomes in patients with gliomas.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 30, 2023
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.
Journal: Cancers
Published: January 19, 2023
A living ex vivo platform for functional, personalized brain cancer diagnosis.
Journal: Cell reports. Medicine
Published: December 16, 2022
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: January 19, 2022
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: September 09, 2021
Last Updated: 09/26/2026